Work

Abstract 4141828: Cardiovascular Adverse Events And Comparative Safety Of Ibrutinib Plus Venetoclax In Untreated Patients With Chronic Lymphocytic Leukemia: A Meta-Analysis Of Randomized Controlled Trials And Systematic Review